Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance studyMargaux M. I. Meslé, Monika Musilová, Mihaela Lazăr et al.|The Lancet Respiratory Medicine|2024Cited by 94
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Jennifer Howard, Esther Kissling et al.|Eurosurveillance|2024Cited by 50
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohortEsther Kissling, Francisco Pozo, Silke Buda et al.|Eurosurveillance|2019Cited by 48
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre studyEsther Kissling, Francisco Pozo, Iván Martínez‐Baz et al.|Influenza and Other Respiratory Viruses|2022Cited by 45
2015/16 I‐<scp>MOVE</scp>/I‐<scp>MOVE</scp>+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among childrenEsther Kissling, Marta Valenciano, Francisco Pozo et al.|Influenza and Other Respiratory Viruses|2017Cited by 37